Detalhe da pesquisa
1.
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Haematologica
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634143
2.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334852
3.
Parent Penalty: Parental Leave Experiences of Trainees and Early-Career Faculty in Oncology Subspecialties.
JCO Oncol Pract
; 19(10): 899-906, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708434
4.
Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study.
J Thromb Haemost
; 20(7): 1645-1652, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426248
5.
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
Blood Adv
; 6(13): 3997-4005, 2022 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507945
6.
HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America.
JCO Glob Oncol
; 8: e2100251, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245084
7.
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
J Hematol Oncol
; 15(1): 96, 2022 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842643
8.
Acute Myeloid Leukemia with t(8;16)(p11.2;p13.3)/ KAT6A-CREBBP in a Patient with an NF1 Germline Mutation and Clinical Presentation Mimicking Acute Promyelocytic Leukemia.
J Assoc Genet Technol
; 46(3): 135-139, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32889804
9.
Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Blood Adv
; 7(1): 88-91, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269847
10.
Acquired BCR-ABL1 fusion and IDH1 clonal evolution following BCL2 inhibitor treatment in refractory acute myeloid leukemia.
Leuk Res
; 100: 106494, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387682